5AM Venture Management, LLC
SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2024-08-14
SEC-registered investment adviser since 2021 · limited liability company
- Assets managed$1.1bn
- Staff32 · 18 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds12 (1 hedge) · $947.0m gross assets
- Website5amventures.com
- Form ADV · 2026-03-30SEC adviser record
- Kindhedge funds, private equity, venture, futures
- Others nearbySan Francisco, CA, Boston, MA, New York, NY
As an employer
- Offices in1 country
- Private fundsventure capital 9, private equity 2, hedge 1
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| San Francisco, CA (main office)United States | about 8 |
| Boston, MAUnited States | 7 |
| New York, NYUnited States | 3 |
US visa salary filings
- Filings FY20251
- Median salary offered$350,000
- Middle half$350,000 – $350,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior Research AnalystNew York, NY | 1 | $350,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SKYE BIOSCIENCE INC COM NEW | $81.5m18.24% | New |
| ENTRADA THERAPEUTICS INC TRDA | $62.8m14.05% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $61.0m13.65% | Reduced -1.2m |
| DIANTHUS THERAPEUTICS INC DNTH | $31.9m7.14% | Reduced -9.1k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $18.4m4.12% | Unchanged |
| BIOHAVEN LTD BHVN | $16.3m3.65% | Added +150.0k |
| TYRA BIOSCIENCES INC TYRA | $15.0m3.36% | Unchanged |
| PHARVARIS N V PHVS | $15.0m3.35% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $14.1m3.15% | Unchanged |
| ERASCA INC ERAS | $12.8m2.85% | New |
| VIKING THERAPEUTICS INC VKTX | $12.6m2.82% | Unchanged |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $12.4m2.78% | Unchanged |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $11.2m2.51% | Unchanged |
| TECTONIC THERAPEUTIC INC TECX | $10.6m2.38% | New |
| VIRIDIAN THERAPEUTICS INC VRDN | $9.6m2.14% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $9.0m2.02% | Unchanged |
| ANAPTYSBIO INC ANAB | $9.0m2.01% | Unchanged |
| GH RESEARCH PLC GHRS | $6.7m1.49% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $6.7m1.49% | Unchanged |
| VOR BIOPHARMA INC COM | $6.4m1.42% | Unchanged |
| SCPHARMACEUTICALS INC SCPH | $5.2m1.17% | Unchanged |
| RALLYBIO CORP COM | $4.9m1.09% | Unchanged |
| Q32 BIO INC QTTB | $4.5m1.01% | Unchanged |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $3.7m0.83% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $2.6m0.59% | Unchanged |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $2.0m0.45% | Unchanged |
| CIDARA THERAPEUTICS INC CDTX | $677.3k0.15% | New |
| EYEPOINT PHARMACEUTICALS INC EYPT | $435.0k0.10% | New |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| MERUS N V MRUS | $24.7m548.8k shares |
| AVIDITY BIOSCIENCES INC RNA | $17.0m665.6k shares |
| CIDARA THERAPEUTICS INC | $1.0m1.1m shares |